Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
This report contains market size and forecasts of Human Milk Oligosaccharides (HMO) in global, including the following market information:
Global Human Milk Oligosaccharides (HMO) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Milk Oligosaccharides (HMO) Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Human Milk Oligosaccharides (HMO) companies in 2021 (%)
The global Human Milk Oligosaccharides (HMO) market was valued at 396 million in 2021 and is projected to reach US$ 1015.7 million by 2028, at a CAGR of 14.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2'-FL & 3-FL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem and Glycom, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Milk Oligosaccharides (HMO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Milk Oligosaccharides (HMO) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Type, 2021 (%)
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Global Human Milk Oligosaccharides (HMO) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, by Application, 2021 (%)
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Global Human Milk Oligosaccharides (HMO) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Human Milk Oligosaccharides (HMO) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Milk Oligosaccharides (HMO) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Milk Oligosaccharides (HMO) revenues share in global market, 2021 (%)
Key companies Human Milk Oligosaccharides (HMO) sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Human Milk Oligosaccharides (HMO) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom